...
首页> 外文期刊>World Journal of Gastroenterology >Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk
【24h】

Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk

机译:脂联素和可溶性血管细胞粘附分子-1的预诊断水平与大肠癌风险相关

获取原文
           

摘要

AIM: To examine the relationships between pre-diagnostic biomarkers and colorectal cancer risk and assess their relevance in predictive models. METHODS: A nested case-control study was designed to include all first primary incident colorectal cancer cases diagnosed between inclusion in the SUpplémentation en VItamines et Minéraux AntioXydants cohort in 1994 and the end of follow-up in 2007. Cases (n = 50) were matched with two randomly selected controls (n = 100). Conditional logistic regression models were used to investigate the associations between pre-diagnostic levels of hs-CRP, adiponectin, leptin, soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1, E-selectin, monocyte chemoattractant protein-1 and colorectal cancer risk. Area under the receiver operating curves (AUC) and relative integrated discrimination improvement (RIDI) statistics were used to assess the discriminatory potential of the models. RESULTS: Plasma adiponectin level was associated with decreased colorectal cancer risk (P for linear trend = 0.03). Quartiles of sVCAM-1 were associated with increased colorectal cancer risk (P for linear trend = 0.02). No association was observed with any of the other biomarkers. Compared to standard models with known risk factors, those including both adiponectin and sVCAM-1 had substantially improved performance for colorectal cancer risk prediction (P for AUC improvement = 0.01, RIDI = 26.5%). CONCLUSION: These results suggest that pre-diagnostic plasma adiponectin and sVCAM-1 levels are associated with decreased and increased colorectal cancer risk, respectively. These relationships must be confirmed in large validation studies.
机译:目的:检查预诊断生物标志物与结直肠癌风险之间的关系,并评估其在预测模型中的相关性。方法:一项嵌套病例对照研究被设计为包括所有1994年被诊断为补充维生素和MinérauxAntioXydant队列的初次结直肠癌病例,并于2007年随访结束。病例(n = 50)为与两个随机选择的控件匹配(n = 100)。使用条件逻辑回归模型研究hs-CRP,脂联素,瘦素,可溶性血管细胞粘附分子-1(sVCAM-1),可溶性细胞间粘附分子-1,E-选择素,单核细胞趋化因子的预诊断水平之间的关联蛋白1和大肠癌的风险。接收器工作曲线下的面积(AUC)和相对综合辨别力改善(RIDI)统计量用于评估模型的歧视潜力。结果:血浆脂联素水平与大肠癌风险降低相关(线性趋势P = 0.03)。 sVCAM-1的四分位数与大肠癌风险增加相关(线性趋势的P = 0.02)。没有观察到与任何其他生物标志物的关联。与具有已知危险因素的标准模型相比,包括脂连蛋白和sVCAM-1在内的模型在大肠癌风险预测方面的性能大大提高(AUC改善的P = 0.01,RIDI = 26.5%)。结论:这些结果表明,诊断前血浆脂联素和sVCAM-1水平分别与大肠癌风险降低和增加有关。这些关系必须在大型验证研究中得到证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号